Fig. 1From: Plasma lipid profiling for the prognosis of 90-day mortality, in-hospital mortality, ICU admission, and severity in bacterial community-acquired pneumonia (CAP)PCA analysis of DI-MS/MS day 1 plasma metabolites comparing non-survivors (n = 75) to survivors (n = 75) of bacterial CAP patients. The cumulative R2X = 0.554 showed a high variability between two cohortsBack to article page